TABLE 2.
Symptoms, hospitalization features, and outcomes of COVID‐19 patients (n = 128)
| Variables | Categories | n (%) |
|---|---|---|
| COVID‐19 related symptoms | Cough | 91 (71.1) |
| Fatigue | 87 (68.0) | |
| Dyspnea | 87 (68.0) | |
| Hyperoxia | 76 (59.4) | |
| Shortness of breath or difficulty breathing | 76 (59.4) | |
| Fever | 67 (52.3) | |
| Headache | 57 (44.5) | |
| Dry mouth | 54 (42.2) | |
| Congestion or runny nose | 54 (42.2) | |
| Anosmia | 52 (40.6) | |
| Diarrhea | 47 (36.7) | |
| Sore throat | 41 (32.0) | |
| Muscle pain | 41 (32.0) | |
| Nausea | 39 (30.5) | |
| Burning eyes | 36 (28.1) | |
| Ageusia | 35 (27.3) | |
| Vomiting | 34 (26.6) | |
| Metallic taste | 28 (21.9) | |
| Dysgeusia | 20 (15.6) | |
| Hypogeusia | 19 (14.8) | |
| Mumps | 10 (7.8) | |
| Conjunctivitis | 5 (3.9) | |
| Skin rashes | 3 (2.3) | |
| Admission and referral to ICU – n (%) | Yes | 69 (53.9) |
| No | 59 (46.1) | |
| Length of stay in ICU (in days) | Mean ± SD | 16.3 ± 13.9 |
| Median (IQR) | 12 (20) | |
| Length of stay in hospital (in days) | Mean ± SD | 15.5 ± 12.0 |
| Median (IQR) | 19 (15) | |
| Need for invasive ventilation in ICU | – | 45 (35.2) |
| Need for tracheostomy in ICU (n = 44) | – | 15 (11.7) |
| Level of symptoms – n (%) | Critical | 43 (33.6) |
| Severe | 12 (9.4) | |
| Moderate | 63 (49.2) | |
| Mild | 10 (7.8) | |
| Hospital endpoint – n (%) | Discharge | 78 (60.9) |
| Death | 31 (24.2) | |
| Discharge to another care facility | 16 (12.5) | |
| Self‐discharge | 3 (2.3) | |
| Mortality rates – n (%) | Admission to ICU (n = 69) | 31 (44.9) |
| Severe‐critical symptoms (n = 55) | 30 (54.5) | |
| Critical symptoms (n = 43) | 29 (67.4) |
Abbreviations: ICU, intensive care unit.